Reaching A1C goal
Right now, there are millions of adults with type 2 diabetes with an A1C higher than 9%.3 While there are many available treatments for these patients, it is important to continue to evaluate their treatment plans.
Choosing too high of a glycemic control target may contribute to A1C levels slowly creeping up over time. Since type 2 diabetes is chronic and progressive, I strive to be vigilant about A1C increases and keep this in mind when choosing reasonable goals for my individual patients.2
In the SUSTAIN 7 trial, we evaluated the percentage of patients achieving an A1C <7%, which the ADA recommends as a reasonable goal for most adults.1,2 Approximately 3 out of 4 patients were able to achieve A1C <7% with Ozempic® 1 mg.1
Regardless of the A1C goal for each patient, their treatment should be helping them achieve glycemic control. If their A1C remains high, they may need a different treatment. With superior glycemic control results vs Trulicity®, Ozempic® may be an appropriate treatment option for my adult patients with type 2 diabetes.